MorphoSys (PK) Stock Price - MPSYF

116.35
-1.40 (-1.19%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
MorphoSys AG (PK) MPSYF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.40 -1.19% 116.35 116.35 116.50 116.50 117.75 14:20:01
Bid Price Ask Price Spread Spread % News
113.31 119.70 6.39 5.34% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 255 $ 116.425 $ 29,688 781 90.75 - 142.75
Last Trade Time Type Quantity Stock Price Currency
14:00:24 100 $ 116.35 USD

MorphoSys (PK) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.67B 22.94M $ -56.17M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
234.10k $ - 0.00% - -

more financials information »

MorphoSys (PK) News

Date Time Source News Article
2/07/202011:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/07/202008:56Edgar (US Regulatory)Statement of Ownership (sc 13g)
2/05/202008:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)
1/13/202009:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)
1/02/202007:44Edgar (US Regulatory)Report of Foreign Issuer (6-k)
1/02/202007:42Edgar (US Regulatory)Report of Foreign Issuer (6-k)
12/03/201908:43Edgar (US Regulatory)Report of Foreign Issuer (6-k)

Latest MPSYF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MPSYF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week124.24124.32116.35124.2912,558-7.89-6.35%
1 Month127.35129.00116.35124.406,891-11.00-8.64%
3 Months126.25142.75116.35128.194,382-9.90-7.84%
6 Months118.25142.75102.50117.139,391-1.90-1.61%
1 Year102.45142.7590.75117.046,81413.9013.57%
3 Years58.00142.8554.24111.491,86058.35100.6%
5 Years89.65142.8536.6390.131,30026.7029.78%

MorphoSys (PK) Description

MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Together with its partners in the pharmaceutical industry, MorphoSys has built a therapeutic pipeline of drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer’s disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. Over 70 therapeutic antibody programs based on the company’s technologies are currently in development, of which 20 are in clinical trials. The company’s most advanced proprietary program is MOR103, a first-in-class antibody against GM-CSF for the treatment of rheumatoid arthritis and multiple sclerosis. MOR103 is part of MorphoSys's collaboration with GlaxoSmithKline. Other proprietary clinical programs include MOR208 and MOR202, both for the treatment of cancer. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR.
Your Recent History
USOTC
MPSYF
MorphoSys ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200225 19:35:42